What is the percentage of patients with disseminated discoid lupus erythematosus who develop SLE?
**Core Concept**
Disseminated discoid lupus erythematosus (DDLE) is a chronic skin condition characterized by the presence of discoid lupus lesions, which are coin-shaped, scaly patches on the skin. DDLE is a subtype of cutaneous lupus erythematosus (CLE), and it is often considered a precursor to systemic lupus erythematosus (SLE), a chronic autoimmune disease that affects multiple organs.
**Why the Correct Answer is Right**
Approximately 22% of patients with DDLE will develop SLE, indicating a significant risk of systemic involvement. This is because both DDLE and SLE share similar pathophysiological mechanisms, including the presence of autoantibodies against nuclear antigens. The development of SLE in patients with DDLE is often preceded by the appearance of systemic symptoms such as fever, malaise, and joint pain. The conversion to SLE is thought to be triggered by the deposition of immune complexes in the skin, which can lead to the activation of the complement system and the release of pro-inflammatory cytokines.
**Why Each Wrong Option is Incorrect**
**Option A:** 2% is too low, as it underestimates the risk of SLE development in patients with DDLE.
**Option C:** 52% is too high, as it overestimates the risk of SLE development in patients with DDLE.
**Option D:** 82% is excessively high, as it implies a nearly certain conversion to SLE, which is not the case.
**Clinical Pearl / High-Yield Fact**
It is essential to note that the presence of mucosal involvement in DDLE, such as lesions on the scalp, face, or mucous membranes, increases the risk of SLE development. Patients with DDLE who exhibit mucosal involvement should be closely monitored for systemic symptoms and considered for systemic lupus screening.
✓ Correct Answer: B. 22%